8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.92%
Growth of 0.92% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
0.32%
Cost increase while Healthcare shows cost reduction. Peter Lynch would examine competitive disadvantages.
3.15%
Gross profit growth below 50% of Healthcare median of 6.56%. Jim Chanos would check for business deterioration.
2.21%
Margin change of 2.21% versus flat Healthcare margins. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-2.10%
Operating expenses reduction while Healthcare median is 0.87%. Seth Klarman would investigate advantages.
-0.12%
Total costs reduction while Healthcare median is 0.38%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
6.37%
D&A change of 6.37% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
22.95%
EBITDA growth exceeding 1.5x Healthcare median of 3.52%. Joel Greenblatt would investigate advantages.
21.83%
Margin change of 21.83% versus flat Healthcare. Walter Schloss would verify quality.
28.75%
Operating income growth exceeding 1.5x Healthcare median of 3.07%. Joel Greenblatt would investigate advantages.
27.58%
Margin change of 27.58% versus flat Healthcare. Walter Schloss would verify quality.
-25.12%
Other expenses reduction while Healthcare median is -3.23%. Seth Klarman would investigate advantages.
25.23%
Pre-tax income growth exceeding 1.5x Healthcare median of 2.93%. Joel Greenblatt would investigate advantages.
24.09%
Margin change of 24.09% versus flat Healthcare. Walter Schloss would verify quality.
23.80%
Tax expense change of 23.80% versus flat Healthcare. Walter Schloss would verify strategy.
25.93%
Net income growth exceeding 1.5x Healthcare median of 2.33%. Joel Greenblatt would investigate advantages.
24.79%
Margin change of 24.79% versus flat Healthcare. Walter Schloss would verify quality.
25.93%
EPS growth exceeding 1.5x Healthcare median of 6.03%. Joel Greenblatt would investigate advantages.
25.93%
Diluted EPS growth exceeding 1.5x Healthcare median of 6.06%. Joel Greenblatt would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.